TetraLogic Pharmaceuticals Corp. Company Profile

Health Care & Life Sciences » Biotechnology | TetraLogic Pharmaceuticals Corp.

TetraLogic Pharmaceuticals Corp.

TetraLogic Pharmaceuticals Corp.
Stock Exchange	NASDAQ Stock Market
EPS	-
Market Cap	$491.75 K
Shares Outstanding	24.47 M
Public Float	21.47 M

Address	343 Phoenixville Pike Malvern Pennsylvania 19355 United States
Employees	-
Website	http://www.tetralogicpharma.com
Updated	07/08/2019
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It products include Birinapant, and SHAPE. The company was founded by John M.